EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.3.2.27 | 1,4-alpha-glucan branching enzyme deficiency |
34405429 |
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency. |
causal interaction therapeutic application unassigned |
4 1 0 |
2.3.2.27 | Abortion, Spontaneous |
16563180 |
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 2 1 |
2.3.2.27 | Abortion, Spontaneous |
27936167 |
The Slavic NBN Founder Mutation: A Role for Reproductive Fitness? |
unassigned |
0 |
2.3.2.27 | Acquired Immunodeficiency Syndrome |
16943852 |
Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G. |
ongoing research therapeutic application unassigned |
2 4 0 |
2.3.2.27 | Acquired Immunodeficiency Syndrome |
17694678 |
A brief history of TRIM5alpha. |
causal interaction therapeutic application unassigned |
4 3 0 |
2.3.2.27 | Acquired Immunodeficiency Syndrome |
18354498 |
The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. |
causal interaction ongoing research therapeutic application unassigned |
3 1 1 0 |
2.3.2.27 | Acquired Immunodeficiency Syndrome |
18583931 |
eIF3-f function in skeletal muscles: to stand at the crossroads of atrophy and hypertrophy. |
therapeutic application unassigned |
2 0 |
2.3.2.27 | Acquired Immunodeficiency Syndrome |
20107597 |
TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 3 4 4 |
2.3.2.27 | Acquired Immunodeficiency Syndrome |
21775457 |
TRIM5 modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys. |
causal interaction ongoing research therapeutic application unassigned |
3 2 4 0 |
2.3.2.27 | Acquired Immunodeficiency Syndrome |
21813188 |
Restriction of the felid lentiviruses by a synthetic feline TRIM5-CypA fusion. |
ongoing research therapeutic application unassigned |
3 1 0 |